Single-Use Negative Pressure Wound Therapy Devices Market Global Report 2028

The single-use negative pressure wound therapy devices market is projected to reach US$ 892.32 million by 2028 from US$ 498.32 million in 2021; it is expected to register a CAGR of 8.8% from 2021 to 2028.

Negative pressure wound therapy (NPWT) is used for managing a wide range of wound types, including traumatic, hard-to-heal, and chronic wounds. It is also used to manage wounds covered with flaps or a skin graft. This therapy is transformed into a medical device such as a single-use NPWT device, which is a small pocket-sized battery-operated device. As the name suggests, these are disposable and portable devices generally used for out-patient care.

The report offers insights and in-depth analysis of the single-use negative pressure wound therapy devices market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the world. It also includes the impact of the COVID-19 pandemic on the market across all the regions. The single-use negative pressure wound therapy devices market witnessed a shortfall at the beginning of the COVID-19 crisis due to disruption in the supply chain and slumped demand due to the lockdown announced by most of the countries worldwide that caused disruptions in manufacturing and operations in the pharmaceutical sector. Additionally, the services for chronic wound care have reduced dramatically in the first and second quarters of 2020 but have normalized at the end of 2020. Furthermore, to reduce cross-contamination through devices, people prefer disposable devices. The increasing use of disposable (single use) NPWT devices is fueling their demand in the global single-use negative pressure wound therapy devices market market. Also, there has been a significant drop in in-patients and out-patients for private hospital chains. To relieve healthcare systems, many clinics have been postponing diagnosis and treatment apart from COVID-19. For instance, in India, the State-run Victoria hospital affiliated with the Bangalore Medical College and Research Institute (BMCRI) was converted into a dedicated COVID-19 facility ever since the pandemic hit Karnataka in March, the functioning of the Mahabodhi Burns Ward in the hospital has not been hit. Despite the pandemic, the hospital continued to operate normally, following all COVID-19 precautions.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Single-Use Negative Pressure Wound Therapy Devices Market: Strategic Insights

Market Size Value in	US$ 498.32 Million in 2021
Market Size Value by	US$ 892.32 Million by 2028
Growth rate	CAGR of 8.8% from 2021 to 2028
Forecast Period	2021-2028
Base Year	2021

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

 Speak to Analyst

Management of chronic wounds in the pandemic was a very difficult task for both sides – patients and physicians. To minimize the exposure risk during the pandemic, patients used disposable devices rather than conventional NPWT devices. Due to health concerns, people preferred using single-use products to manage chronic and acute wounds. This factor supported the growth of the market during the pandemic situation. The single-use negative pressure wound therapy devices market is segmented into wound type, end user, and geography. The market, based on region, is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America.

Lucrative Regions for Single-Use Negative Pressure Wound Therapy Devices Market

Market Insights
Increase in Cases of Burns

In 2019, a total of 8,378,122 new cases of burns were identified worldwide. Burn fatality rates have been declining in many high-income nations, but child burn deaths are now approximately 7 times greater in low- and middle-income countries than in high-income countries. The single-use negative pressure wound therapy system is used to treat acute and chronic wounds and closed surgical incisions with low to moderate exudate levels. Negative pressure wound therapy (NPWT) involves applying negative pressure (a vacuum) to a wound to manage it and promote healing. Topical negative pressure (TNP) therapy, vacuum aided closure (VAC), and sealed surface wound suction are among the other names for NPWT. NPWT is used to help drain excess fluid and enhance localized blood flow in burn patients. It has been suggested that the action of NPWT may result in increased oxygen and nutrition being delivered to the burn, promoting healing. The single-use negative pressure wound therapy system is for individuals who would benefit from a suction device (negative pressure wound therapy), as it helps promote wound healing by removing low to moderate amounts of exudate and infectious debris. Chronic, acute, traumatic, subacute, and dehisced wounds; partial-thickness burns; ulcers (such as diabetic or pressure); flaps and grafts; closed surgical incisions are all examples of acceptable wound types.

Moreover, according to the Children's Burn Trust and the British Burn Association, 625 children are admitted to an NHS Burns Service each month owing to burn or scald injuries. In 2017, the NHS's burns and scalds services treated more than 15,000 patients with these injuries, with a total cost of more than US$ 24.94 million (i.e., GBP 20 million). More than 40 of the total burn treatment admissions in 2017 were classified as extremely serious, with treatment procedures costing more than US$ 118,455.50 (GBP 95,000) per person. Burns caused by home and industrial mishaps are rising in developing regions such as Asia Pacific, Africa, and the Middle East. Therefore, the market for single-use negative pressure wound care devices is being driven by an increase in the number of occurrences of burns and similar injuries.

Wound Type-Based Insights

The global single-use negative pressure wound therapy devices market, based on wound type, has been segmented into ulcers, surgical, traumatic, sports injuries, flaps and grafts, and burns. In 2022, the traumatic segment accounted for the largest share of the market; it is further expected to continue its dominance over the forecast period. This type of wound is the most common due to the increasing prevalence of road accidents and trauma cases. Moreover, the traumatic segment is expected to register the highest CAGR during 2021–2028.

Single-Use Negative Pressure Wound Therapy Devices Market, by Product – 2022 and 2028

Access Data

End User-Based Insights

Based on end user, the single-use negative pressure wound therapy devices market has been segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held the largest share of the market in 2022 and is estimated to register the highest CAGR during the forecast period.

The single-use negative pressure wound therapy devices market players adopt organic strategies such as product launch and expansion to expand their footprint and product portfolio worldwide and meet the growing demand.

Geography-Based Insights

By geography, the single-use negative pressure wound therapy devices market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Company-Based Insights

Cardinal Health Inc; ConvaTec Group Plc; Carilex Medical; Genadyne Biotechnologies, Inc.; H and R Healthcare; Lohmann & Rauscher GmbH & Co. KG; Medela AG; Mölnlycke Health Care AB; Paul Hartmann Ag; and Smith & Nephew plc are among the leading companies operating in the single-use negative pressure wound therapy devices market.